Intertek board minded to recommend EQT’s £60 per share offer

Intertek's board said it would be minded to recommend EQT's final cash offer of £60.00 per share, up from prior proposals of £51.50, £54.00 and £58.00 per share. The deal terms also allow Intertek to pay a final dividend of up to 107.7 pence per share for FY2025 without reducing the cash consideration, pending AGM approval on May 20. EQT's deadline to announce a firm offer has been extended to 5:00 pm on June 11.

Analysis

The market is treating this as a clean takeout path, but the more important signal is that EQT is trying to force a valuation reset without paying for optionality. If Intertek accepts, the bid sets a useful benchmark for other UK mid-cap “quality compounders” where boards can credibly defend standalone plans yet are vulnerable once a sponsor reaches a near-final number. That matters because it can tighten the bid/ask spread for adjacent outsourcing, testing, and assurance names with similar cash generation and governance profiles.

The dividend carve-out is the most underappreciated lever here: it effectively transfers a near-term cash return to target holders while preserving headline consideration, which reduces the chance of a competing management-led defense and makes acceptance easier for income-sensitive institutions. The flip side is that any delay or failure before the June deadline is likely to compress the stock back toward a pre-bid fundamental range quickly, since the “free dividend plus offer” trade becomes much less compelling once confirmatory diligence exposes any normalization in margins or working capital.

For EQT, the asymmetry is better than it looks because the financial terms are stated as final; that caps economic downside if the process stalls, but creates reputational risk if it walks after public signaling. The real tail risk is a third-party topping bid, not because it is likely, but because it would force EQT to either break its discipline or concede a process-driven re-rating. That makes the next two to four weeks a catalyst window, not a long-duration thesis.

Contrarian view: the consensus may be overestimating the probability that “final” means done. In sponsor-led UK deals, the diligence phase often surfaces small but meaningful normalization issues that can kill value even after a public board recommendation. If the deal falls apart, the stock likely de-rates faster than the market expects because the strategic review pause removes the near-term standalone re-rating narrative at the same time.

Key Decisions for Investors

• Long EQT on any pre-deadline weakness into June 11: the downside is capped by stated final terms, while successful execution should re-rate the shares modestly on de-risking; target a 1-2% event-driven move, stop if the company signals diligence friction.
• Sell downside volatility in Intertek only if you can hedge with stock: short-dated put spreads into the June 11 deadline can monetize elevated event premium, but keep size small because a failed deal likely mean-reverts sharply lower.
• Pair trade: long Intertek / short a basket of UK quality-mid-cap industrials only if you believe deal completion probability is >70%; otherwise avoid directional exposure because the optionality is binary and the standalone thesis is paused.
• If you want cleaner expression, buy a short-dated call spread in EQT into the deadline: limited premium outlay, positive convexity on deal completion, and defined loss if the process breaks.
• Watch for a topping-bid signal in the next 2-3 weeks; if one emerges, rotate out of any sponsor-long position immediately because the economics shift from execution to auction and EQT’s final-price discipline becomes a liability.